RxSight
RXST
45 hedge funds and large institutions have $108M invested in RxSight in 2022 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 21 increasing their positions, 5 reducing their positions, and 7 closing their positions.
320% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 5
71% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 7
44% more capital invested
Capital invested by funds: $75M → $108M (+$33.4M)
13% more funds holding
Funds holding: 40 → 45 (+5)
7.55% more ownership
Funds ownership: 24.37% → 31.92% (+7.6%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$8.68M |
| 2 |
BlackRock
New York
|
+$4.08M |
| 3 |
CAM
Cresset Asset Management
Chicago,
Illinois
|
+$3.79M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.61M |
| 5 |
BM
Bridger Management
New York
|
+$2.38M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Russell Investments Group
London,
United Kingdom
|
-$490K |
| 2 |
IWM
IHT Wealth Management
Chicago,
Illinois
|
-$376K |
| 3 |
State of Wisconsin Investment Board
Madison,
Wisconsin
|
-$281K |
| 4 |
E
Ergoteles
New York
|
-$273K |
| 5 |
State of Tennessee, Department of Treasury
Nashville,
Tennessee
|
-$226K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
GCM
51
Ghisallo Capital Management
Boston,
Massachusetts
| – | -$113K | -10,000 | Closed |
|
52
Marshall Wace
London,
United Kingdom
| – | -$68K | -6,034 | Closed |
|
RXST Hedge Fund Activity: Q1 2022 in Review
45 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in RxSight (RXST) for Q1 2022, worth a combined $108M — up 44% from $75M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new RXST positions and 7 closed out — a net gain of 5 holders — while 21 added to existing stakes and 5 trimmed.
The largest buyer was Millennium Management, adding an estimated $8.68M. The largest seller was Russell Investments Group, exiting entirely with an estimated $490K sold.
- 45 institutional investors held RxSight (RXST) as of Q1 2022, up from 40 in Q4 2021.
- Funds reported $108M of RxSight stock for Q1 2022, up 44% quarter-over-quarter.
- 12 funds opened new RxSight positions in Q1 2022 and 7 closed out, a net change of +5 holders.
- The largest RxSight buyer in Q1 2022 was Millennium Management, an estimated $8.68M added.
- The largest RxSight seller in Q1 2022 was Russell Investments Group, an estimated $490K sold.
Based on aggregated 13F filings for Q1 2022.